Here is how the new list of Warren Buffett and Berkshire Hathaway's public share holding looks as of June 30, 2016.
Usually the term "hostile takeover" is an exaggeration, but Sanofi's takeover bid for Medivation actually looks pretty hostile, given that it is now trying to oust the entire board.
Trey Thoelcke Many companies are being discussed as Zika virus winners, but the reality is that many of them are so small or have sketchy histories. This is why we are featuring seven notable…
Being the wealthiest man in the world on paper tends to draw some attention. This is why investors and outsiders watch new equity investment positions taken by, or sold by, Warren Buffett…
One time when missing earnings estimates doesn't matter much is when there is bidding war for the company. That's the position that Medivation found itself in.
Warren Buffett has now released the official equity holdings of Berkshire Hathaway Inc. (NYSE: BRK-A) as of December 31, 2016. That makes this the official Buffett stocks for 2016, but we would…
Warren Buffett and Berkshire Hathaway have released their official equity holdings of Berkshire Hathaway as of September 30, 2015.
RBC Capital Markets downgraded MannKind on Wednesday to Underperform from a Market Perform, with a price target of a mere dollar.
courtesy of WhiteHouse.govWarren Buffett and Berkshire Hathaway Inc. (NYSE: BRK-A) have released the official equity holdings of Berkshire Hathaway as of June 30, 2015. It has been the case for years now…
ThinkstockRegeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi (NYSE: SNY) announced last Friday that the U.S. Food and Drug Administration (FDA) approved Praluent (alirocumab) Injection. Praluent is indicated as an adjunct to diet…
When the American Society of Clinical Oncology (ASCO) decided to create a rating scale for cancer drugs, it certainly must have expected to get some pushback.
This coming week is likely to be a serious one in the fight against cholesterol. FDA panels are evaluating more than just one drug candidate.
After looking at the recent recovery, and after looking over the more recent news that has come out after earnings, 24/7 Wall St. wants to see if MannKind shares have finally reached…
Biotech company MannKind reported its first-quarter financial results after the markets closed Thursday.
Thursday's top analyst upgrades, downgrades and initiations from 24/7 Wall St. include Coach, Garmin, Intelsat, Potbelly, SolarCity and Valero Energy.
